These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

979 related items for PubMed ID: 11498544

  • 1. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.
    Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV.
    Science; 2001 Sep 28; 293(5539):2449-52. PubMed ID: 11498544
    [Abstract] [Full Text] [Related]

  • 2. Cell biology. Life without caveolae.
    Parton RG.
    Science; 2001 Sep 28; 293(5539):2404-5. PubMed ID: 11577223
    [No Abstract] [Full Text] [Related]

  • 3. Caveolae and caveolins in the cardiovascular system.
    Gratton JP, Bernatchez P, Sessa WC.
    Circ Res; 2004 Jun 11; 94(11):1408-17. PubMed ID: 15192036
    [Abstract] [Full Text] [Related]

  • 4. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
    Linder AE, McCluskey LP, Cole KR, Lanning KM, Webb RC.
    J Pharmacol Exp Ther; 2005 Jul 11; 314(1):9-15. PubMed ID: 15778264
    [Abstract] [Full Text] [Related]

  • 5. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, Ghisdal P, Grégoire V, Dessy C, Balligand JL, Feron O.
    Circ Res; 2004 Jul 23; 95(2):154-61. PubMed ID: 15205364
    [Abstract] [Full Text] [Related]

  • 6. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.
    Rath G, Dessy C, Feron O.
    J Physiol Pharmacol; 2009 Oct 23; 60 Suppl 4():105-9. PubMed ID: 20083858
    [Abstract] [Full Text] [Related]

  • 7. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
    Hnasko R, Lisanti MP.
    Mol Interv; 2003 Dec 23; 3(8):445-64. PubMed ID: 14993453
    [Abstract] [Full Text] [Related]

  • 8. Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease.
    Xu Y, Buikema H, van Gilst WH, Henning RH.
    Eur J Pharmacol; 2008 May 13; 585(2-3):256-60. PubMed ID: 18423600
    [Abstract] [Full Text] [Related]

  • 9. Caveolae, lipid rafts, and vascular disease.
    Li XA, Everson WV, Smart EJ.
    Trends Cardiovasc Med; 2005 Apr 13; 15(3):92-6. PubMed ID: 16039968
    [Abstract] [Full Text] [Related]

  • 10. Caveolin, caveolae, and endothelial cell function.
    Frank PG, Woodman SE, Park DS, Lisanti MP.
    Arterioscler Thromb Vasc Biol; 2003 Jul 01; 23(7):1161-8. PubMed ID: 12689915
    [Abstract] [Full Text] [Related]

  • 11. Genetic ablation of caveolin-1 confers protection against atherosclerosis.
    Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP.
    Arterioscler Thromb Vasc Biol; 2004 Jan 01; 24(1):98-105. PubMed ID: 14563650
    [Abstract] [Full Text] [Related]

  • 12. The role of caveolin-1 in cardiovascular regulation.
    Rahman A, Swärd K.
    Acta Physiol (Oxf); 2009 Feb 01; 195(2):231-45. PubMed ID: 18826501
    [Abstract] [Full Text] [Related]

  • 13. Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells.
    Saliez J, Bouzin C, Rath G, Ghisdal P, Desjardins F, Rezzani R, Rodella LF, Vriens J, Nilius B, Feron O, Balligand JL, Dessy C.
    Circulation; 2008 Feb 26; 117(8):1065-74. PubMed ID: 18268148
    [Abstract] [Full Text] [Related]

  • 14. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease.
    Quest AF, Leyton L, Párraga M.
    Biochem Cell Biol; 2004 Feb 26; 82(1):129-44. PubMed ID: 15052333
    [Abstract] [Full Text] [Related]

  • 15. Caveolae: a once-elusive structure gets some respect.
    Marx J.
    Science; 2001 Nov 30; 294(5548):1862-5. PubMed ID: 11729300
    [No Abstract] [Full Text] [Related]

  • 16. Caveolin-1 and caveolae act as regulators of mitogenic signaling in vascular smooth muscle cells.
    Thyberg J.
    Arterioscler Thromb Vasc Biol; 2003 Sep 01; 23(9):1481-3. PubMed ID: 12972458
    [No Abstract] [Full Text] [Related]

  • 17. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM, Eby JC, Disatnik MH, Rando TA.
    J Cell Sci; 2003 Dec 01; 116(Pt 23):4739-49. PubMed ID: 14600260
    [Abstract] [Full Text] [Related]

  • 18. Calcium extrusion by plasma membrane calcium pump is impaired in caveolin-1 knockout mouse small intestine.
    El-Yazbi AF, Cho WJ, Schulz R, Daniel EE.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):80-7. PubMed ID: 18634779
    [Abstract] [Full Text] [Related]

  • 19. Role of caveolae and caveolins in health and disease.
    Cohen AW, Hnasko R, Schubert W, Lisanti MP.
    Physiol Rev; 2004 Oct 04; 84(4):1341-79. PubMed ID: 15383654
    [Abstract] [Full Text] [Related]

  • 20. Caveolin-1 null (-/-) mice show dramatic reductions in life span.
    Park DS, Cohen AW, Frank PG, Razani B, Lee H, Williams TM, Chandra M, Shirani J, De Souza AP, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP.
    Biochemistry; 2003 Dec 30; 42(51):15124-31. PubMed ID: 14690422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.